LLY Eli Lilly and Company

USD 749.92 -3.49 ( -0.46)%
Icon

Eli Lilly and Company (LLY) Stock Analysis and Price Targets

COMMON STOCK | Drug Manufacturers - General | NYE
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

Buy

Average User
Rating

USD 749.92

-3.49 (-0.46)%

USD 737.03B

4.14M

USD 995.06(+32.69%)

USD 392.00 (-47.73%)

Icon

LLY

Eli Lilly and Company (USD)
COMMON STOCK | NYE
USD 749.92
-3.49 ( -0.46)%

Eli Lilly and Company (LLY) Stock Forecast

Show ratings and price targets of :
USD 995.06
(+32.69%)

Based on the Eli Lilly and Company stock forecast from 16 analysts, the average analyst target price for Eli Lilly and Company is USD 995.06 over the next 12 months. Eli Lilly and Company’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Eli Lilly and Company is Neutral, which is based on 9 positive signals and 9 negative signals. At the last closing, Eli Lilly and Company’s stock price was USD 749.92. Eli Lilly and Company’s stock price has changed by -4.62% over the past week, -17.24% over the past month and +26.55% over the last year.

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...